Here, we designed and conducted computational studies of several complexes of iron metal (III) and thiourea-derived compounds with NUDT5 to assess the possibility of developing thiourea compounds as therapeutic drug candidates for breast cancer through NUDT5 inhibition. This evidence concerns the gene NUDT5 and breast carcinoma.